UK experts certainly participated in the EFSA’s detailed review of the health data. The EFSA concluded that,
“glyphosate is unlikely to pose a carcinogenic hazard”.
and we agree with that conclusion. A wealth of studies is taking place. There have been huge studies in America and studies in various places in the world. From all these studies, the majority of experts concluded that there was very little evidence for an association between glyphosate-based formulations and cancer.
Is my noble friend aware that the branded product in the UK for use in gardens has been on the market since the 1970s? Is it not unbelievable now, with the evidence from Europe, that this product, in its slightly diluted format for people to use in their gardens, can possibly be causing any real problems?
What my noble friend says is true. Each pesticide has specific conditions of authorisation, which are set out on its label. The level of safety must be achieved without reliance on training or special equipment. As my noble friend says, for domestic use glyphosate is very much diluted and comes mainly in trigger packs, which means that it is very safe for use.
I thank the noble Lord for his kind words. I hope that your Lordships will have patience while I learn the ways of this House. Indeed, I feel that behind me my noble friend Lord Howe, who has indeed done an incredible job over the past 18 years, is sitting on his hands at the moment, longing to rush to the Dispatch Box, push me aside and take over this brief.
To answer the noble Lord’s question, the Secretary of State intimated that we are determined to guarantee that personal data are protected, and we are enthusiastic about reacting to the benefits of sharing them. Indeed, Professor Peter Weissberg of the British Heart Foundation stated:
“Locked inside our medical records is a mine of vital information that can help medical scientists make discoveries that can improve … and save lives”.
We must keep this at the forefront of our minds.
Is it not a tragedy that 700,000 patients have decided to opt out of this scheme? Is this not comparable to what happened with MMR, when mothers opted out but were subsequently found to have done so to the detriment of their children? Against that background, while of course one protects the rights of any individual to make their own decision, will the Government ensure that all publicity is put behind what my noble friend has said in her answers today?
My Lords, I think that is very true. It is important that we take the patients with us. We need to remember that an informed patient is not a panicked patient. That is why a pathfinder will be started first to ensure that we have everything in place before we roll out these data nationwide.